Amarin Corp Plc (AMRN)

[couldbebetter]

Alm2, Very sensible post. Outside of a legal miracle, the only way that
the US market has a chance to be salvaged is through a BP BO that has a
competent and effective sales force selling Vascepa. Thero was wrong
about being able to grow the US market as well as limited supply for
generics. Pfizer knows how to market drugs and any involvement with
Vascepa at this time would include the tailwinds of the goodwill that
exists with Pfizer due to its success with the C-19 vaccine.

In Europe, Pfizer, (or any other Euro-centric BP) could use its massive
sales and marketing network their to ramp up sales. China as well could
be helped with a BP owning AMRN as a BP acquirer could find creative ways
to help with the launch of Vascepa in China. I see no advantage for
AMRN to wait for a BO. The sooner BP owns this the longer they will
be able to grow sales. Should Vascepa become a drug to treat the the
inflammatory effects of the virus, a BP such as Pfizer could take full
advantage of that as well. This is all basic common sense. I sure hope
KM understands this and does not make the same mistakes Thero made.
(The number one being that he did not sell the company.) Vascepa is a
drug that BP needs to market before it is accepted as a legitimate
Cardiovascular medication...Thinking otherwise is idiocy.